SCHEMBL17953765

SCHEMBL17953765

c1ccc(-n2c3ccccc3c3cc(-c4ccc5sc6ccc(-c7ccc8c9c(cccc79)-c7ccccc7-8)cc6c5c4)ccc32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
KDM4E B2RXH2 1/20 0.42
TSPO P30536 2/20 0.32
ALOX5 P09917 1/20 0.32
PTGER4 P35408 1/20 0.31
ALDH1A1 P00352 2/20 0.31
MEN1 O00255 1/20 0.31
GAA P10253 1/20 0.31
KMT2A Q03164 1/20 0.31
HSD17B10 Q99714 2/20 0.31
CRHBP P24387 1/20 0.31
CRHR2 Q13324 1/20 0.31
KEAP1 Q14145 1/20 0.31
NFE2L2 Q16236 1/20 0.31
HDAC4 P56524 1/20 0.30
HPGD P15428 1/20 0.30
TSHR P16473 1/20 0.30
MAPK1 P28482 1/20 0.30
CASP1 P29466 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17953831 0.96 ATM (0.38) ATML3MBTL1KDM4ETSPOALOX5
SCHEMBL17953820 0.96 ATM (0.38) ATML3MBTL1KDM4ETSPOALOX5
SCHEMBL17953856 0.95 ALOX5 (0.36) ATML3MBTL1KDM4EALOX5ALDH1A1
SCHEMBL17953768 0.94 ATM (0.41) ATML3MBTL1KDM4EALOX5ALDH1A1
SCHEMBL15480206 0.92 L3MBTL1 (0.50) ATML3MBTL1KDM4ETSPOPTGER4
SCHEMBL14756619 0.91 ALOX5 (0.34) ATML3MBTL1KDM4ETSPOALOX5
SCHEMBL17953769 0.91 ATM (0.39) ATML3MBTL1KDM4EALOX5ALDH1A1
SCHEMBL17953663 0.90 L3MBTL1 (0.51) ATML3MBTL1KDM4ETSPOPTGER4
SCHEMBL17953801 0.90 ALOX5 (0.36) ATML3MBTL1KDM4ETSPOALOX5
SCHEMBL14756656 0.89 ATM (0.34) ATML3MBTL1KDM4ETSPOALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10622569-B2 Compound, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2020-04-14 US disclosed
US-20160218299-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-07-28 US disclosed
US-20160218299-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160218299-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE EFNA1, L1CAM, LEF1 ATM 3520/4885L3MBTL1 1706/4885KDM4E 2030/4885
US-10622569-B2 Compound, organic electroluminescent element, and electronic device EFNA1, L1CAM, LEF1 ATM 3520/4885L3MBTL1 1706/4885KDM4E 2030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.